MITA News

  • MITA News

    The future of medicine lies in treatments that are tailored to individual patients’ needs. This approach directs the appropriate care to each patient and maximizes healthcare outcomes. Today, “precision” medicine is a growing movement that utilizes information about an individual’s biology to personalize healthcare decision making. Advanced medical imaging has emerged as an important complement to this nascent trend leading to enhanced diagnosis, informed treatment options and targeted treatments.

  • MITA News

    Representatives of the American College of Radiology, the Medical Imaging & Technology Alliance and the Lung Cancer Alliance met on Thursday with CMS officials in Washington to try to convince the agency to cover CT scans for Medicare beneficiaries who have been heavy smokers.

  • MITA News

    Oncology departments can now provide their patients with a better PET/CT imaging experience using Toshiba America Medical Systems, Inc.’s all-new Celesteion (pending 510(k) clearance). The versatile system combines high performance PET and CT for all radiation and oncology imaging needs, including tumor detection, treatment evaluation and CT simulation.

  • MITA News

    Politicians have gotten involved and are campaigning to have lung cancer screening covered by Medicare, which insures people 65 years of age and older. Members of the US House and Senate are asking the Centers for Medicare & Medicaid Services (CMS) to approve coverage of lung cancer screening with low-dose CT.

  • MITA News

    The Medical Imaging & Technology Alliance (MITA) today applauded Reps. Charles Boustany, Jr. MD (R-La.), John Barrow (D-Ga.), Jim Renacci (R-Ohio) and Richard E. Neal (D-Mass.) for their leadership in advocating for Medicare coverage of low-dose computed tomography (LDCT) for patients at high risk of lung cancer.

  • MITA News

    Should Medicare beneficiaries have access to the same testing benefits as individuals with private health insurance? That question is at the crux of Medicare’s deliberation of a coverage decision for imaging high risk beneficiaries for lung cancer. – See more at: http://www.diagnosticimaging.com/low-dose/low-dose-lung-ct-can-save-thousands-lives-right-now#sthash.jmHFLUYO.dpuf

  • MITA News

    In an effort to reduce unnecessary care and waste in the health care system, researchers from Harvard Medical School Department of Health Care Policy went after certain tests and procedures that Medicare beneficiaries receive which, according to empirical studies, have been shown to offer little or no health benefit.

  • MITA News

    According to a recent report from the American Cancer Society, cancer survival rates in the United States are climbing. While this welcome trend is a result of a combination of scientific, technological and medical advances, there is no doubt that innovations in medical imaging and radiation therapy technologies play a critical role in the fight against cancer.

  • MITA News

    A Medicare advisory panel voted “low confidence” on the benefits of low-dose computed tomography for lung cancer screening at an April 30 meeting in Baltimore, Md. The Medicare Evidence Development & Coverage Advisory Committee voted “low confidence” on the benefits of low-dose computed tomography for lung cancer screening outweighing any risks posed by CT screening for the disease.

  • MITA News

    The American College of Radiology (ACR) and the Medical Imaging and Technology Alliance (MITA) are weighing in on a negative vote by a Medicare advisory committee regarding coverage of low-dose CT (LDCT) for lung cancer screening.